489341243	489341243	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
31768190	31768190	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7060668	7060668	CD	B-NP	O
|	|	CC	I-NP	O
10/28/2005	10/28/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/17/2005	1/17/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/9/2005	4/9/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SATERFIELD	SATERFIELD	NNP	B-NP	O
,	,	,	O	O
JAYSON	JAYSON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Milbrown	Milbrown	NNP	B-NP	O
Ae	Ae	NNP	I-NP	O
A	A	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS/DIAGNOSES	PROBLEMS/DIAGNOSES	NN	B-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	I-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
falls	fall	NNS	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
since	since	IN	B-PP	O
7/18	7/18	CD	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
at	at	IN	B-PP	O
Stusem	Stusem	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
found	find	VBN	B-VP	O
on	on	IN	B-PP	O
routine	routine	JJ	B-NP	O
labs	lab	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
3.6	3.6	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
6/29	6/29	CD	B-NP	O
and	and	CC	O	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
2.2	2.2	CD	B-NP	O
in	in	IN	B-PP	O
6/8	6/8	CD	B-NP	O
BUN	BUN	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
96	96	CD	B-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
down	down	IN	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
44	44	CD	B-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	NNS	I-NP	O
being	be	VBG	B-VP	O
told	tell	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
during	during	IN	B-PP	O
an	an	DT	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
SITMH	SITMH	NN	B-NP	B-protein
in	in	IN	B-PP	O
7/18	7/18	CD	B-NP	O
,	,	,	O	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
heavy	heavy	JJ	B-NP	O
NSAID	NSAID	NN	I-NP	O
use	use	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
stopped	stop	VBD	B-VP	O
using	use	VBG	I-VP	O
NSAIDs	NSAID	NNS	B-NP	O
in	in	IN	B-PP	O
6/8	6/8	CD	B-NP	O
Prior	Prior	NNP	I-NP	O
to	to	TO	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
feeling	feeling	NN	B-NP	O
like	like	IN	B-PP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
retaining	retain	VBG	I-VP	O
fluid	fluid	NN	B-NP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
x2-3	x2-3	NN	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
chest	chest	VBP	B-VP	O
pain	pain	NN	B-NP	O
,	,	,	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
or	or	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
reports	report	VBZ	B-VP	O
dysuria	dysuria	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
indwelling	indwell	VBG	B-VP	O
Foley	Foley	NNP	B-NP	O
since	since	IN	B-PP	O
6/8	6/8	CD	B-NP	O
Denies	Deny	NNS	I-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
melena	melena	NN	I-NP	O
or	or	CC	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
six	six	CD	I-NP	O
months	month	NNS	I-NP	O
but	but	CC	I-NP	O
reports	report	NNS	I-NP	O
melena	melena	NN	I-NP	O
and	and	CC	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
intermittently	intermittently	RB	B-ADVP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
diverticula	diverticula	NN	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
60-90	60-90	CD	B-NP	O
,	,	,	O	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
120-140	120-140	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2-4	2-4	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
nonmobile	nonmobile	JJ	I-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Sclerae	Sclerae	NNP	B-NP	O
were	be	VBD	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
conjunctival	conjunctival	JJ	I-NP	O
pallor	pallor	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
assessed	assess	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
II/VI	II/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
audible	audible	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
base	base	NN	I-NP	O
on	on	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
lung	lung	NN	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sound	sound	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Pertinent	Pertinent	JJ	B-NP	O
lab	lab	NN	I-NP	O
results	result	NNS	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HPI	HPI	NN	I-NP	B-DNA
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
DURING	DURING	VBG	B-VP	O
THE	THE	DT	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1/13/05	1/13/05	CD	B-NP	O
creation	creation	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
;	;	:	O	O
7/7/05	7/7/05	CD	B-NP	O
EGD	EGD	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Renal	Renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
initially	initially	RB	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
prerenal	prerenal	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
BUN/creatinine	BUN/creatinine	NN	I-NP	O
ratio	ratio	NN	I-NP	O
and	and	CC	I-NP	O
FENA	FENA	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
FEBUN	FEBUN	NN	I-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
abundant	abundant	JJ	B-NP	O
granular	granular	JJ	I-NP	O
casts	cast	NNS	I-NP	O
.	.	.	O	O

ATN	ATN	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
possibility	possibility	NN	B-NP	O
but	but	CC	O	O
urine	urine	NN	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
29	29	CD	B-NP	O
.	.	.	O	O

Postrenal	Postrenal	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
hydronephrosis	hydronephrosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
once	once	RB	B-ADVP	O
outside	outside	IN	B-PP	O
hospital	hospital	NN	B-NP	O
records	record	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
fail	fail	VB	I-VP	O
volume	volume	NN	B-NP	O
challenge	challenge	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
past	past	IN	B-PP	O
3.2	3.2	CD	B-NP	O
from	from	IN	B-PP	O
10/18/05	10/18/05	CD	B-NP	O
to	to	TO	B-PP	O
4/20/05	4/20/05	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
AV	AV	NN	B-NP	O
fistula	fistula	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
GFR	GFR	NN	B-NP	B-protein
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
17	17	CD	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
improving	improve	VBG	I-VP	O
.	.	.	O	O

AV	AV	NN	B-NP	O
fistula	fistula	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
1/13/05	1/13/05	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
waxing	wax	VBG	I-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
of	of	IN	B-PP	O
3.1	3.1	CD	B-NP	O
.	.	.	O	O

Daily	Daily	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
usually	usually	RB	B-ADVP	O
approximately	approximately	RB	B-NP	O
600-700	600-700	CD	I-NP	O
mL	mL	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
diuretics	diuretic	NNS	I-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
well	well	RB	B-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
precipitate	precipitate	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
kidney	kidney	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Colonoscopy	Colonoscopy	NN	B-NP	O
in	in	IN	B-PP	O
2001/2003	2001/2003	CD	B-NP	O
notable	notable	JJ	I-NP	O
for	for	IN	B-PP	O
diverticula	diverticula	NN	B-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
generally	generally	RB	B-NP	O
guaiac	guaiac	JJ	I-NP	O
positive	positive	JJ	I-NP	O
brown	brown	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
bump	bump	VB	I-VP	O
appropriately	appropriately	RB	B-ADVP	O
after	after	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
went	go	VBD	B-VP	O
from	from	IN	B-PP	O
23.3-30	23.3-30	CD	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
setting	setting	NN	I-NP	O
and	and	CC	I-NP	O
plans	plan	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
to	to	TO	B-VP	O
look	look	VB	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
procedures	procedure	NNS	I-NP	O
were	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
in	in	IN	B-PP	O
OR	OR	NN	B-NP	O
and	and	CC	O	O
attempted	attempt	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/05	2/22/05	CD	B-NP	O
.	.	.	O	O

EGD	EGD	NN	B-NP	B-protein
successfully	successfully	RB	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
,	,	,	O	O
nonbleeding	nonbleeding	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
duodenal	duodenal	JJ	B-NP	O
mass	mass	NN	I-NP	O
with	with	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
heterotopia	heterotopia	NN	I-NP	O
.	.	.	O	O

H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
stool	stool	NN	I-NP	O
antigen	antigen	NN	I-NP	O
and	and	CC	I-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Colonoscopy	Colonoscopy	NN	B-NP	O
not	not	RB	B-VP	O
obtained	obtain	VBN	I-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
past	past	IN	B-PP	O
the	the	DT	B-NP	O
rectum	rectum	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
required	require	VBN	B-NP	O
general	general	JJ	I-NP	O
anesthesia/ETT	anesthesia/ETT	NN	I-NP	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
thighs	thigh	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular/Pump	Cardiovascular/Pump	NN	B-NP	O
-	-	HYPH	I-NP	O
ECHO	ECHO	NN	I-NP	B-protein
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rhythm	rhythm	NN	I-NP	O
or	or	CC	I-NP	O
ischemia	ischemia	NN	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
HDL	HDL	NN	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme/normocytic	Heme/normocytic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

Iron	Iron	NNP	B-NP	O
stores	store	NNS	I-NP	O
repleted	replete	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
iron	iron	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
possible	possible	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
EPO	EPO	NN	I-NP	B-protein
.	.	.	O	O

EPO	EPO	NN	B-NP	B-protein
level	level	NN	I-NP	O
checked	check	VBD	B-VP	O
low	low	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
normal	normal	JJ	I-ADJP	O
,	,	,	O	O
may	may	MD	B-VP	O
ultimately	ultimately	RB	I-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
Epogen	Epogen	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis/paroxysmal	prophylaxis/paroxysmal	JJ	I-NP	O
a-fib	a-fib	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
arrival	arrival	JJ	B-ADJP	O
.	.	.	O	O

Supratherapeutic	Supratherapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
Coumadin	Coumadin	NNP	B-NP	O
held	hold	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
until	until	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
1.5	1.5	CD	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
platelets	platelet	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
heparin	heparin	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
200s	200s	CD	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
,	,	,	O	O
so	so	IN	O	O
heparin	heparin	NN	B-NP	O
stopped	stop	VBD	B-VP	O
.	.	.	O	O

PF4	PF4	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
negative	negative	JJ	I-NP	O
x1	x1	NN	I-NP	O
and	and	CC	O	O
borderline	borderline	JJ	B-NP	B-protein
x1	x1	NN	I-NP	I-protein
.	.	.	O	O

PF4	PF4	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
all	all	DT	B-NP	O
heparin	heparin	NN	I-NP	B-protein
products	product	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
flush	flush	NN	B-NP	O
is	be	VBZ	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
after	after	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
at	at	IN	B-PP	O
12.5	12.5	CD	B-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	IN	B-PP	O
three	three	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
2	2	CD	B-NP	O
.	.	.	O	O

Target	Target	NN	B-NP	B-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
2-2	2-2	JJ	B-NP	O
.5	.5	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Tarbripin	Tarbripin	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
915-360-5305	915-360-5305	CD	B-NP	O
.	.	.	O	O

INRs	INR	NNS	B-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
faxed	fax	VBN	I-VP	O
to	to	TO	B-PP	O
clinic	clinic	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	I-NP	O
adjustments	adjustment	NNS	I-NP	O
in	in	IN	B-PP	O
doses	dose	NNS	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
TSH	TSH	NN	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
5.5	5.5	CD	I-NP	O
,	,	,	O	O
so	so	IN	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
UTI/proteus	UTI/proteus	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
renally	renally	RB	B-VP	O
dosed	dose	VBN	I-VP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
urine	urine	NN	I-NP	O
dirty	dirty	NN	I-NP	O
,	,	,	O	O
so	so	RB	O	O
p.o.	p.o.	RB	B-ADVP	O
Cipro	Cipro	NNP	B-NP	O
started	start	VBD	B-VP	O
for	for	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
UTI	UTI	NN	B-NP	B-protein
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
indwelling	indwell	VBG	B-VP	O
Foley	Foley	NNP	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
low-grade	low-grade	JJ	B-NP	O
temp	temp	NN	I-NP	O
to	to	TO	B-PP	O
max	max	NN	B-NP	B-protein
100.4	100.4	CD	I-NP	I-protein
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	JJ	I-NP	O
unchanged	unchanged	JJ	I-NP	O
but	but	CC	O	O
only	only	RB	B-NP	O
portable	portable	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
immobility	immobility	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Empirically	Empirically	RB	B-ADVP	O
treating	treat	VBG	B-VP	O
for	for	IN	B-PP	O
nosocomial	nosocomial	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
with	with	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
levo/cefpodox/azithro	levo/cefpodox/azithro	FW	I-NP	O
x10	x10	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
by	by	IN	B-PP	O
11/19/05	11/19/05	CD	B-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Allergy	Allergy	NN	B-NP	O
:	:	:	O	O
Postnasal	Postnasal	JJ	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

Rhinorrhea	Rhinorrhea	NNP	B-NP	O
.	.	.	O	O

Continued	Continued	NNP	B-NP	O
Claritin	Claritin	NNP	I-NP	O
and	and	CC	O	O
Flonase	Flonase	NNP	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Psyche	Psyche	NNP	B-NP	O
:	:	:	O	O
Zoloft	Zoloft	NNP	B-NP	O
continued	continue	VBD	B-VP	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Intermittent	Intermittent	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
intermittently	intermittently	RB	B-ADVP	O
desaturates	desaturate	VBZ	B-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
to	to	TO	B-PP	O
80s	80s	CD	B-NP	O
but	but	CC	O	O
always	always	RB	B-ADVP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
repositioning	repositioning	NN	B-NP	O
and	and	CC	I-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
respiratory	respiratory	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
deconditioning	deconditioning	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
restrictive	restrictive	VB	I-VP	O
lung	lung	NN	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

Continuing	Continue	VBG	B-VP	O
Flovent	Flovent	NNP	B-NP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
and	and	CC	I-NP	O
albuterol	albuterol	NN	I-NP	O
nebs	neb	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
for	for	IN	B-PP	O
wheezing	wheeze	VBG	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
for	for	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Oncology	Oncology	NNP	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
mass	mass	NN	I-NP	O
last	last	JJ	B-ADJP	O
evaluated	evaluate	VBN	B-VP	O
in	in	IN	B-PP	O
4/20	4/20	CD	B-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
surgery	surgery	NN	B-NP	O
would	would	MD	B-VP	O
determine	determine	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Oncology	Oncology	NNP	B-NP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
patient	patient	NN	B-NP	O
during	during	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
stay	stay	NN	I-NP	O
but	but	CC	O	O
will	will	MD	B-VP	O
schedule	schedule	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
followup	followup	NN	I-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
issue	issue	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
tamoxifen	tamoxifen	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Gentle	Gentle	NN	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
.	.	.	O	O

KEY	KEY	NN	B-NP	O
FEATURES	FEATURES	NNS	I-NP	O
OF	OF	IN	B-PP	O
PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAM	EXAM	NN	I-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Essentially	Essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.	q.	NN	B-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
ECASA	ECASA	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Catapres	Catapres	NNP	B-NP	O
0.1	0.1	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
q.	q.	NN	I-NP	O
weekly	weekly	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
tartarate	tartarate	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
ocean	ocean	NN	B-NP	O
spray	spray	NN	I-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
dry	dry	JJ	B-NP	O
nose	nose	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x10	x10	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
doxazosin	doxazosin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Claritin	Claritin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
110	110	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
cefpodoxime	cefpodoxime	NN	B-NP	O
proxetil	proxetil	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
x10	x10	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Flonase	Flonase	NN	B-NP	O
one	one	CD	I-NP	O
spray	spray	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
24	24	CD	I-NP	O
x10	x10	CD	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
rehab	rehab	VB	I-VP	O
facility	facility	NN	B-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gleen	Gleen	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oncologist	oncologist	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
,	,	,	O	O
dates	date	NNS	B-NP	O
of	of	IN	B-PP	O
appointments	appointment	NNS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
forwarded	forward	VBN	I-VP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
facility	facility	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-9678771	9-9678771	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Carlton	Carlton	NNP	B-NP	O
Ahlstedt	Ahlstedt	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LAURION	LAURION	NN	B-NP	O
,	,	,	O	O
ROBERT	ROBERT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GOROVITZ	GOROVITZ	NNP	B-NP	O
,	,	,	O	O
EDGAR	EDGAR	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0867345	0867345	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/20/05	1/20/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/20/05	1/20/05	CD	B-NP	O

